Gianenrico Senna to Young Adult
This is a "connection" page, showing publications Gianenrico Senna has written about Young Adult.
Connection Strength
0.089
-
Safety of uSCIT-MPL-4: prevalence and risk factors of systemic reactions in real life. Immunotherapy. 2019 06; 11(9):783-794.
Score: 0.022
-
Biologic Therapy in a Patient with Asthma and Nasal Polyps. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1700-1701.
Score: 0.022
-
Spontaneous pneumomediastinum complicating severe acute asthma exacerbation in adult patients. J Asthma. 2018 09; 55(9):1028-1034.
Score: 0.020
-
The Characteristics of Severe Chronic Upper-Airway Disease (SCUAD) in Patients with Allergic Rhinitis: A Real-Life Multicenter Cross-Sectional Italian Study. Int Arch Allergy Immunol. 2019; 178(4):333-337.
Score: 0.005
-
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life. Pulm Pharmacol Ther. 2019 02; 54:87-89.
Score: 0.005
-
Prevalence and features of asthma-chronic obstructive pulmonary disease overlap in Northern Italy general population. J Asthma. 2019 01; 56(1):27-33.
Score: 0.005
-
Evaluation of asthma control in the pharmacy: an Italian cross-sectional study. Eur Ann Allergy Clin Immunol. 2017 Sep; 49(5):225-230.
Score: 0.005
-
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice. J Allergy Clin Immunol Pract. 2018 Jan - Feb; 6(1):208-218.
Score: 0.005